Tacrolimus (FK506) - Its effects on intestinal glucose transport

Transplantation

Volumn 61, Issue 4, 1996, Pages 630-634

  Yanchar, Natalie L ^a   Riegel, Timothy M ^a   Martin, Gary ^a   Fedorak, Richard N ^a   Kneteman, Norman M ^a   Sigalet, David L ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Department of Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTETATE TECHNETIUM TC 99M; TACROLIMUS;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSPLANTATION; MALE; NONHUMAN; NUTRITION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; CELL MEMBRANE PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EATING; GLUCOSE; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; RATS; RATS, INBRED LEW; TACROLIMUS;

EID: 0029914869     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602270-00019     Document Type: Article

References (39)

1. Goulet O, Revillon Y, Brousse N, et al. Successful small bowel transplantation in an infant. Transplantation 1992; 53: 940.
2. Goulet O, Revillon Y, Brousse N, et al. Normal growth four and half years after small bowel transplantation using Cyclosporine A in an infant. In: Abstracts of the IIIrd International Symposium on Small Bowel Transplantation, Paris. 1993: O7.
3. Grant D, Wall W, Mimeault R, Zhong R, et al. Successful small-bowel-liver transplantation. Lancet 1990; 335: 181.
4. Todo S, Tzakis A, Reyes J, et al. Clinical small bowel or small bowel plus liver transplantation under FK506. Transplant Proc 1991; 23: 3093.
5. Todo S, Tzakis AG, Abu-Elmagd K, et al. Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation 1992; 53: 369.
6. Abu-Elmagd K, Todo S, Tzakis A, et al. Three years clinical experience with intestinal transplantation. Journal Am Coll Surg 1994; 179: 385.
7. Todo S, Tzakis A, Reyes J, et al. Clinical intestinal transplantation: three-year experience. In: Abstracts of the IIIrd International Symposium on Small Bowel Transplantation, Paris. 1993: O2.
8. Wallemacq PE, Reding R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem 1993; 39: 2219.
9. Sadawa S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent FK506: In vitro effects on the cloned T-cell activation. J Immunol 1987; 139: 1797.
10. Schreiber SL, Crabtree GR. The mechanism of action of CyA and FK506. Immunol Today 1992; 13: 136.
11. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-CyA and FKBP-FK506 complexes. Cell 1991; 66: 807.
12. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK506 and cyclosporin A. Nature 1991; 352: 803.
13. Schraut WH, Lee KKW, Sitrin M. Recipient growth and nutritional status following transplantation of segmental small-bowel allografts. J Surg Res 1987; 43: 1.
14. Raju S, Fujiwara H, Grogan JB, Achord JL. Long-term nutritional function of orthotopic small bowel autotransplants. J Surg Res 1989; 46: 142.
15. Sigalet DL, Kneteman NM, Fedorak RN, Kizilisik AT, Thomson ABR. Intestinal function following allogeneic small intestinal transplantation in the rat. Transplantation 1992; 53: 264.
16. Watson AJM, Lear PA, Montgomery A, et al. Water, electrolyte, glucose, and glycine absorption in rat small intestinal transplants. Gastroenterology 1988; 94: 863.
17. Sigalet DL, Kneteman NM, Thomson ABR. Cyclosporin reduces nutrient absorption by normal bowel. Clin Res 1991; 39: 18A.
18. Sigalet DL, Kneteman NM, Thomson ABR. The effects of cyclosporine on normal bowel. Transplantation 1991; 51: 1296.
19. Sigalet DL, Kneteman NM, Thomson ABR. Reduction of nutrient absorption in normal rats by cyclosporine. Transplantation 1992; 53: 1103.
20. Sigalet DL, Kneteman NM, Simpson I, Walker K, Thomson ABR. Intestinal permeability after small intestinal transplantation and cyclosporine treatment. Transplant Proc 1992; 24: 1120.
21. Canadian Council on Animal Care. Guide to the care and use of experimental animals, 1980.
22. Hoffman AL, Makowka L, Banner B, et al. The use of FK506 for small intestine allotransplantation: Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation 1990; 49: 483.
23. Association of Official Analytical Chemists. Methods of analysis, 23rd ed. Washington, D. C.: AOAC, 1986.
24. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1956; 226: 497.
25. Loebl J. Image analysis: principles and practice. Great Britain: Joyce Loebl, 1985.
26. Field M, Fromm D, McColl I. Ion transport in rabbit ileal mucosa: I, Na and Cl fluxes and short-circuit current. Am J Physiol 1971; 220: 1388.
27. Fedorak RN, Chang EB, Madara JL, Field M. Intestinal adaptation to diabetes: altered Na-dependent nutrient absorption in streptozocin-treated chronically diabetic rats. J Clin Invest 1987; 79: 1571.
28. Ueki M, Yasunami Y, Ina K, et al. Diabetogenic effects of FK506 on renal subcapsular islet isografts in rats, Diabetes Res Clin Pract 1993; 20: 11.
29. Nalesnik MA, Todo S, Murase N, et al. Toxicology of FK506 in the Lewis rat. Transplant Proc 1987; 29: 89.
30. Wijnen RMH, Ericzon BG, Tiebosch ATGM, Beysens AJ, Groth CG, Kootstra G. Toxicity of FK506 in the cynomolgus monkey: noncorrelation with FK506 serum levels. Transplant Proc 1991; 23: 3101.
31. Reese JC, Fairchild RB, Solomon H, Warty V, Kaminski DL. The effect of FK506 on canine bile flow. Transplantation 1993; 56: 1162.
32. 51Cr-labelled ethylenediaminetetraacetate as markers of intestinal permeability in man. Cin Sci 1987; 73: 197.
33. Philpott DJ, Butzner JD, Meddings JB. Regulation of intestinal glucose transport. Can J Physiol Pharmacol 1992; 70: 1201.
34. Bjarnson I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832.
35. Mandel LJ, Bacallao R, Zampighi G. Uncoupling of the molecular 'fence' and paracellular 'gate' functions in epithelial tight junctions. Nature 1993; 361: 552.
36. Madsen KL, Yanchar NL, Sigalet DL, Reigel T, Fedorak RN. FK506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology, 1995; 108: .
37. Krentz AJ, Dousset B, Mayer D, et al. Metabolic effects of cyclosporin A and FK506 in liver transplant recipients. Diabetes 1993; 42: 1753.
38. Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplam and mitochondria of rat liver. Biochem J 1967; 103: 514.
39. Henke W, Jung K. Comparison of the effects of the immunosuppressive agents FK506 and cyclosporin A on rat kidney mitochondria. Biochem Pharmacol 1993; 46: 829.